Masters Capital Management LLC Virios Therapeutics, Inc. Transaction History

Masters Capital Management LLC

  • $1.74 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
BUY
$4.61 - $6.56 $230,500 - $328,000
50,000 Added 8.33%
650,000 $3.44 Million
Q1 2021

May 17, 2021
BUY
$5.01 - $8.84 $761,735 - $1.34 Million
152,043 Added 33.94%
600,000 $3.44 Million
Q4 2020

Feb 16, 2021
BUY
$7.51 - $16.71 $3.36 Million - $7.49 Million
447,957 New
447,957 $3.36 Million

Others Institutions Holding VIRI

# of Institutions
27
Shares Held
991K
Call Options Held
0
Put Options Held
0
View Full List

About Virios Therapeutics, Inc.

VIRI Quotes by TradingView
  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $3.12M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Masters Capital Management LLC Portfolio

Follow Masters Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Masters Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Masters Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email